Join the Small Cell Lung Cancer group to help and get support from people like you.
Small Cell Lung Cancer News (Page 2)
Related terms: Cancer, Lung, Small Cell, Lung Cancer, Small Cell, SCLC
E-Cigarette Use Linked to Lower Use of Lung Cancer Screening
TUESDAY, July 9, 2024 – Electronic cigarette use is associated with a lower use of lung cancer screening (LCS), according to a research letter published online July 2 in JAMA Network Open. Qian...
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is Low
FRIDAY, June 21, 2024 – The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study...
Swimming 'Microbots' Could Speed Meds to Lung Tumors, Early Study Suggests
FRIDAY, June 14, 2024 – Scientists have developed microscopic robots capable of swimming through the lungs to deliver chemotherapy directly to lung cancer cells. In early testing, these...
Another Study Finds Lung Cancer Screening Saves Lives
TUESDAY, June 11, 2024 — Lung cancer patients who underwent screening were more apt to be diagnosed at earlier stages and have better outcomes than patients who were not screened, new research shows. ...
AI Blood-Based Lung Cancer Screening Test Developed for Fragmentome
MONDAY, June 10, 2024 – A novel blood-based lung cancer screening test has been developed and validated using genome-wide sequencing to analyze cell-free DNA (cfDNA) fragmentation profiles,...
Lung Cancer Screening Increases Earlier-Stage Diagnoses, Improves Survival
MONDAY, June 10, 2024 – Lung cancer screening (LCS) is associated with earlier-stage diagnoses and improved survival, according to a study published online June 10 in Cancer. Donna M. Edwards, M.D.,...
Just 18% of People Who Need Lung Cancer Screening Get It
MONDAY, June 10, 2024 – Only a fraction of Americans are getting recommended lung cancer screenings, new research shows. While rates overall are up slightly, fewer than 1 in 5 people who are...
FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer
THOUSAND OAKS, Calif., May 16, 2024 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Imdelltra™ (tarlatamab-dlle) for the treatment of ...
FDA Approves New Drug for Deadly Lung Cancer, Imdelltra
FRIDAY, MAY 17, 2024 – The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is...
Immunotherapy Before and After Surgery Boosts Lung Cancer Survival
THURSDAY, May 16, 2024 – Immunotherapy can boost the survival of early-stage lung cancer patients eligible for surgery when it’s combined with chemotherapy, a new clinical trial reports. Those who g...
FDA Approves Zepzelca (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer
Madrid and Dublin, June 15th, 2020.- PharmaMar (MSE:PHM) has today announced, along with Jazz Pharmaceuticals plc (Nasdaq: JAZZ), that the U.S. Food and Drug Administration (FDA) has approved...
Imfinzi (durvalumab) Approved in the US for Extensive-Stage Small Cell Lung Cancer
30 March 2020 – AstraZeneca’s Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with sta...
FDA Approves Keytruda (pembrolizumab) for the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
KENILWORTH, N.J.--(BUSINESS WIRE)--June 18, 2019 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...
FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer
South San Francisco, CA – March 18, 2019 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq...
FDA Approves Opdivo (nivolumab) for Certain Patients with Previously Treated Small Cell Lung Cancer
PRINCETON, N.J.--(BUSINESS WIRE)--August 17, 2018 – Bristol-Myers Squibb Company (NYSE:BMY) today announced that Opdivo (nivolumab) received approval from the U.S. Food and Drug Administration (FDA)...